Greg Ahn 

Greg graduated from Cornell University and joined the group in September 2017, as a research scientist.  Greg will be working on the synthesis of novel molecules as potential treatments for a number of neurodegenerative diseases.  In the future, Greg plans to pursue a career in medicine.

Mike Shultis 

Mike is a chemistry graduate from Northeastern University and joined the group in April 2018, as a research scientist. Mike is working on the synthesis of novel molecules for a the EAAT2 project.  In the future, Mike plans to pursue a career in medicine.

Lisa Montagnon
Lisa joined the group in September 2017.  She is an undergraduate chemistry student from Bath University UK. Lisa is synthesizing new heterocycles for the EAAT2 project for the treatment of AD and ALS. 

Dr. Kevin Hodgetts

Director of ‚ÄčThe Laboratory for Drug Discovery in Neurodegeneration

65 Landsdowne Street 

Cambridge, Massachusetts 02139

U.S.A.


Telephone: 617-768-8640 

Email:  khodgetts@bwh.harvard.edu

 

Contact